BERKSHIRE ASSET MANAGEMENT LLC/PA - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 136 filers reported holding IMMUNITYBIO INC in Q2 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
BERKSHIRE ASSET MANAGEMENT LLC/PA ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q1 2022$84,000
-7.7%
15,0000.0%0.01%
-16.7%
Q4 2021$91,000
-53.3%
15,000
-25.0%
0.01%
-53.8%
Q3 2021$195,000
-31.8%
20,0000.0%0.01%
-31.6%
Q2 2021$286,000
-19.7%
20,000
+33.3%
0.02%
-26.9%
Q1 2021$356,00015,0000.03%
Other shareholders
IMMUNITYBIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 251,556$1,387,0001.70%
ORACLE INVESTMENT MANAGEMENT INC 315,322$1,567,0000.89%
HARBOURVEST PARTNERS LLC 335,709$1,668,0000.54%
ALLEN HOLDING INC /NY 687,571$3,417,0000.54%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$479,0000.21%
SHEETS SMITH WEALTH MANAGEMENT 207,926$1,033,0000.17%
Clearwater Capital Advisors, LLC 185,911$924,0000.13%
WEALTH EFFECTS LLC 28,500$142,0000.09%
Virtus ETF Advisers LLC 35,048$174,0000.07%
Vident Investment Advisory, LLC 195,127$969,0000.03%
View complete list of IMMUNITYBIO INC shareholders